Perspective · 10 Sep 2026
Conference abstractPublished 29 Jun 2017
Association between higher levels of pro-inflammatory cytokines (TNF, IL-6) and IL-5 in induced sputum and lower lung function among subjects with asthma
Federal University of Bahia (UFBA), Brazil
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim: Asthma is a chronic and heterogeneous disease presenting various phenotypes. The aim of this study was to assess airway inflammation among subjects with asthma by counting cells and measuring cytokines in the sputum to search for associations with clinical features of the disease. Methods: We studied 66 subjects, divided into three asthma subgroups [16 with severe asthma resistant to treatment (SAR), 22 with severe asthma controlled with treatment (SAC), 19 with mild to moderate asthma (MMA)] and a group with no asthma (NA) including 9 subjects. Total cellularity of the sputum samples was counted using a hemocytometer and differential cytology was observed in cytospin. Measurements of cytokines were performed by Luminex (Upstate/Millipore system âÂ?Â?Flex kitâÂ?). Statistical analysis was performed using nonparametric tests. Results: Sputum of SAR had higher percentage of neutrophils as compared with MMA (p=0.05) and higher percentage of eosinophils compared with NA (p=0.02). TNF was increased in SAR compared to NA, MMA and SAC (p=0.001). Subjects with asthma, and treated with high doses of inhaled corticosteroids presented higher levels of TNF (p=0.02), IL-6 (p=0.01) and IL-5 (p=0.03). Increased TNF production was associated with reduced lung function before and after bronchodilator as measured by FEV1% [p=0.00 for both), FEV1/FVC% (p=0.03 and p=0.02 respectively) and FEF25-75% (p=0.00 for both). Conclusion: Increased inflammatory cytokines (TNF, IL-6 and IL-5) and number of inflammatory cells (neutrophils and eosinophils), were associated with SAR, and high levels of TNF were associated with worse lung function. Our findings support the concept these subjects may have an end phenotype of asthma related to airway inflammation that goes beyond the Th2 type response, and that it is indeed resistant to high doses inhaled corticosteroids, requiring a different approach to treatment.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Emilia M M de Andrade Belitardo”
- BylineArticles whose byline prints “Paula Cristina Almeida”
- BylineArticles whose byline prints “Eduardo Santos da Silva”
- BylineArticles whose byline prints “Samara Sa Teles”
- BylineArticles whose byline prints “Alana Alcantara Galvao”
- BylineArticles whose byline prints “Luis Gustavo C”
- BylineArticles whose byline prints “Alvaro A Cruz”
- BylineArticles whose byline prints “Neuza M Alcantara-Neves”
